Children's Automated Respiration Monitor (ChARM) for Child Pneumonia Diagnosis by Community Health Workers in Mali
1 other identifier
interventional
141
1 country
2
Brief Summary
The primary objective of this study is to estimate the impact of a self-monitoring tool (ChARM), used as a teaching/monitoring device, on the CHWs respiratory rate counting accuracy when assessing children under the age of 5 years with suspected pneumonia symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 14, 2017
CompletedStudy Start
First participant enrolled
March 5, 2018
CompletedFirst Posted
Study publicly available on registry
March 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2019
CompletedJune 25, 2019
June 1, 2019
11 months
December 14, 2017
June 21, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acute Respiratory Illness (ARI) Case fatality rate
Acute Respiratory Illness (ARI) Case fatality rate defined as number of deaths from respiratory infections among children diagnosed with respiratory infections
8 months
Secondary Outcomes (5)
Respiratory rate counting accuracy
8 months
Proportion of pneumonia cases detected and treated by CHWs
8 months
Proportion of suspected severe pneumonia cases referred by CHWs to the CSCom
8 months
Proportion of suspected pneumonia cases in the community who sought care from a CHW
8 months
Accuracy in drug management and procurement requests
8 months
Study Arms (3)
Intervention Group A
ACTIVE COMPARATORCHWs trained in ChARM and using ChARM as a self-monitoring tool for 8 months while counting respiratory rate of children under 5 visually using a timer. Intervention: The Children's Respiration Monitor (also known as ChARM) device is routinely used to diagnose Pneumonia cases but in this study it will be used as a self-monitoring and teaching aide for strengthening CHWs skills.
Intervention Group B
ACTIVE COMPARATORCHWs trained in ChARM and using ChARM as a self-monitoring tool for 4 months while counting respiratory rate of children under 5 visually using a time; then discontinue using ChARM and continue to monitor the respiratory rate visually using a timer only for the remaining 4 months. Intervention: The Children's Respiration Monitor (also known as ChARM) device is routinely used to diagnose Pneumonia cases but in this study it will be used as a self-monitoring and teaching aide for strengthening CHWs skills.
Control Group C
NO INTERVENTIONCHWs who did not receive the ChARM training and will be monitoring the respiratory rate of children under 5 visually using a timer only, as per the MoH traditional training.
Interventions
The Philips CHARM (children's automatic respiratory monitor) is specifically designed to detect pneumonia in low resource areas. The lightweight measuring device sits on a child's or infant's chest, secured by a strap and measures respiration rate (fast breathing) through an ingenious algorithm. In this study ChARM will be used as a self monitoring and teaching aide by the CHWS.
Eligibility Criteria
You may qualify if:
- Be currently providing iCCM services on a full-time basis to the populations they are serving.
- Have completed the Malian Ministry of Health basic community health care worker training provided as part of the 2016-2020 Strengthening Maternal, Newborn and Child Health project.
- Are using a device (a respiratory timer) as part of their basic MoH training package, or have a cell phone to use to count the respiratory rates of children under five with suspected symptoms of pneumonia.
- Be willing to participate in a trial to study the impact of using ChARM as a self-monitoring tool to improve the capacity to detect pneumonia.
You may not qualify if:
- CHWs in conflict ridden geographical areas within the district or not, providing consistent services on a full-time basis to the populations they are serving.
- CHWs not willing to participate in the trial.
- CHWs who do not have a device (watch, respiratory timer or cell phone) to support measurement of respiratory rates and who are not routinely counting respiratory rate to diagnose suspected pneumonia.
- CHWs who did not complete the MoH basic training for CHWs provided through the 2016-2020 Strengthening Maternal, Newborn and Child Health program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Diego Bassanilead
- Canadian Red Crosscollaborator
Study Sites (2)
iCCM sites
Banamba, Koulikoro, Mali
iCCM Sites
Koulikoro, Mali
Study Officials
- PRINCIPAL INVESTIGATOR
Diego G Bassani, PhD
University of Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director, International Program Evaluation Unit (IPE), Center for Global Child Health
Study Record Dates
First Submitted
December 14, 2017
First Posted
March 7, 2018
Study Start
March 5, 2018
Primary Completion
January 21, 2019
Study Completion
January 21, 2019
Last Updated
June 25, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- March 2018 - March 2019
- Access Criteria
- Study Protocol and Clinical Study Reports will be shared with local partners - Mali Red Cross, Canadian Red Cross and Mali Ministry of Health
Plan to share Study Protocol and Clinical Study Reports with local study partners with the purposes of future decisions on future CHW training